Ro gaat samenwerking aan met Eli Lilly om toegang tot obesitasbehandeling te verbeteren; aandelen Hims & Hers Health dalen ...

Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $30.87 which represents a decrease of $-1.76 or -5.39% from the prior close of $32.63. The stock opened at $32.25 and touched a low ...

Shares of Hims & Hers Health Inc. slid to a three-week low on Wednesday before recovering some losses, even as retail ...

Op maandag handhaafde Canaccord Genuity een Koop-advies voor Hims & Hers Health, Inc. (NYSE:HIMS), terwijl het koersdoel voor het aandeel werd verhoogd van $28 naar $38. Het besluit van het bedrijf ...

Hims & Hers Health's P/B ratio indicates that the market value of the company exceeds its book value by a factor of 16, so ...

Hims & Hers Health is financially strong with minimal debt and a dominant market share. Find out what makes HIMS stock a ...

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) has received a consensus rating of “Hold” from the sixteen analysts ...

This might be the case for shares of Hims & Hers Health Inc. (NYSE: HIMS), as the stock is now rallying by over 6% the ...

Hims & Hers Health offers telehealth and online prescription services across the US. The company saw a 41% increase in subscribers, reaching 1.7 million in early 2024. Investors can buy Hims ...

Hims & Hers Health, Inc.'s stock dropped over 25% over the last 2 days due to Amazon's entry into the hair loss and ED markets, but I believe investor pessimism is overblown. Despite Amazon's comp ...

The Chief Financial Officer of Hims & Hers Health, Inc. (NYSE:HIMS), Okupe Oluyemi, has sold a total of 9,868 shares of the company's Class A common stock, resulting in a near... ByInvesting.com ...